Literature DB >> 10864933

Self recognition in the Ig superfamily. Identification of precise subdomains in carcinoembryonic antigen required for intercellular adhesion.

M Taheri1, U Saragovi, A Fuks, J Makkerh, J Mort, C P Stanners.   

Abstract

The homophilic binding of extracellular domains of membrane-bound immunoglobulin superfamily (IgSF) molecules is often required for intercellular adhesion and signaling. Carcinoembryonic antigen (CEA), a member of the IgSF, is a widely used tumor marker that functions in vitro as a homotypic intercellular adhesion molecule. CEA has also been shown to contribute to tumorigenicity by inhibiting cellular differentiation, an effect that requires the homophilic binding of its extracellular domains. It was of interest, therefore, to identify small subdomain sequences in CEA that could serve as a focus in the design of peptides that disrupt CEA-mediated intercellular adhesion. Three subdomains in the N-terminal domain of CEA, identified by site-directed deletions and point mutations, were shown to be required for intercellular adhesion. Cyclized peptides representing two of these subdomains, (42)NRQII and (80)QNDTG, were found to be effective in blocking CEA-mediated cellular aggregation when added to CEA-expressing transfectants in suspension. Intermolecular binding involving each of these subdomains is therefore essential for intercellular adhesion and cannot be compensated for by known binding contributions of other regions in the CEA molecule. In further support of this assumption, the binding epitope of an anti-CEA monoclonal antibody (monoclonal antibody A20) known to block CEA-mediated adhesion, was shown to bridge two of the three required subdomains: (42)NRQII and (30)GYSWYK.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10864933     DOI: 10.1074/jbc.M909242199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Blocking the attachment of cancer cells in vivo with DNA aptamers displaying anti-adhesive properties against the carcinoembryonic antigen.

Authors:  Erik W Orava; Aws Abdul-Wahid; Eric H-B Huang; Amirul Islam Mallick; Jean Gariépy
Journal:  Mol Oncol       Date:  2013-04-11       Impact factor: 6.603

2.  Glycosylation Alters Dimerization Properties of a Cell-surface Signaling Protein, Carcinoembryonic Antigen-related Cell Adhesion Molecule 1 (CEACAM1).

Authors:  You Zhuo; Jeong-Yeh Yang; Kelley W Moremen; James H Prestegard
Journal:  J Biol Chem       Date:  2016-07-28       Impact factor: 5.157

3.  A subfamily of Dr adhesins of Escherichia coli bind independently to decay-accelerating factor and the N-domain of carcinoembryonic antigen.

Authors:  Natalia Korotkova; Ernesto Cota; Yuri Lebedin; Severine Monpouet; Julie Guignot; Alain L Servin; Steve Matthews; Steve L Moseley
Journal:  J Biol Chem       Date:  2006-08-01       Impact factor: 5.157

4.  The carcinoembryonic antigen IgV-like N domain plays a critical role in the implantation of metastatic tumor cells.

Authors:  Aws Abdul-Wahid; Eric H-B Huang; Marzena Cydzik; Eleonora Bolewska-Pedyczak; Jean Gariépy
Journal:  Mol Oncol       Date:  2013-12-17       Impact factor: 6.603

5.  Identification of CD226 ligand on colo205 cell surface.

Authors:  Kai Sun; Bo-Quan Jin; Qi Feng; Yong Zhu; Kun Yang; Xue-Song Liu; Bang-Quan Dong
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

6.  Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma.

Authors:  Marijo Bilusic; Christopher R Heery; Philip M Arlen; Myrna Rauckhorst; David Apelian; Kwong Y Tsang; Jo A Tucker; Caroline Jochems; Jeffrey Schlom; James L Gulley; Ravi A Madan
Journal:  Cancer Immunol Immunother       Date:  2013-12-07       Impact factor: 6.968

7.  Binding of Dr adhesins of Escherichia coli to carcinoembryonic antigen triggers receptor dissociation.

Authors:  Natalia Korotkova; Yi Yang; Isolde Le Trong; Ernesto Cota; Borries Demeler; Jan Marchant; Wendy E Thomas; Ronald E Stenkamp; Steve L Moseley; Steve Matthews
Journal:  Mol Microbiol       Date:  2007-12-11       Impact factor: 3.501

8.  A novel anti-CEACAM5 monoclonal antibody, CC4, suppresses colorectal tumor growth and enhances NK cells-mediated tumor immunity.

Authors:  Chaogu Zheng; Jing Feng; Di Lu; Ping Wang; Shu Xing; Jean-Luc Coll; Dongling Yang; Xiyun Yan
Journal:  PLoS One       Date:  2011-06-22       Impact factor: 3.240

9.  Conservation of pregnancy-specific glycoprotein (PSG) N domains following independent expansions of the gene families in rodents and primates.

Authors:  Andrew S McLellan; Wolfgang Zimmermann; Tom Moore
Journal:  BMC Evol Biol       Date:  2005-06-29       Impact factor: 3.260

Review 10.  Advances in Screening and Development of Therapeutic Aptamers Against Cancer Cells.

Authors:  Zheng Li; Xuekun Fu; Jie Huang; Peiyuan Zeng; Yuhong Huang; Xinxin Chen; Chao Liang
Journal:  Front Cell Dev Biol       Date:  2021-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.